awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40398050-1577C5A9-1080-45B2-A59C-DF83AD8F4505
Q40398050-1577C5A9-1080-45B2-A59C-DF83AD8F4505
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40398050-1577C5A9-1080-45B2-A59C-DF83AD8F4505
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.
P2860
Q40398050-1577C5A9-1080-45B2-A59C-DF83AD8F4505
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40398050-1577C5A9-1080-45B2-A59C-DF83AD8F4505
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cb63a120816e469ee1d80935b8014c66a12675f
P2860
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations.